Trademarkia Logo

Canada

C$
KRAZATI (STYLIZED)
FORMALIZED

on 17 Sept 2024

Last Applicant/ Owned by

MIRATI THERAPEUTICS INC.

3545 Cray CourtSan Diego, CA 92121

US

Serial Number

2350066 filed on 17th Sept 2024

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

KRAZATI (STYLIZED)

Trademark usage description

pharmaceutical preparations; pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of cancer; pharmaceut Read More

Vienna Information


26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 11

Quadrilaterals containing one or more triangles or lines forming an angleQuadrilatères contenant un ou plusieurs triangles ou des lignes formant un angle

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Classification Information


Class [005]
Pharmaceutical preparations; pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for oncology; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung cancer; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceutical preparations containing low molecular weight compounds; pharmaceutical preparations containing small molecules for the treatment of cancer; pharmaceutical preparations containing low molecular weight compounds for the treatment of infectious diseases; pharmaceutical preparations containing small molecules for the treatment of lung cancer; pharmaceutical preparations containing small molecules for the treatment of non-small cell lung cancer; pharmaceuticals with low molecular weight compounds for the treatment of colorectal cancer; pharmaceutical preparations containing small molecules for the treatment of pancreatic cancer; pharmaceutical drug compounds; pharmaceutical drug compounds for the treatment of cancer; pharmaceutical preparations containing inhibitors; pharmaceutical preparations containing inhibitors for the treatment of cancer; pharmaceutical preparations for the treatment of solid tumors; pharmaceutical preparations for the treatment of advanced solid tumors.


Classification kind code

12

Class [042]
Research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; pharmaceutical research and development; providing information in the field of scientific and medical research relating to pharmaceuticals.


Classification kind code

12

Mark Details


Serial Number

2350066

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 3rd Oct 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 17th Sept 2024
Filed
Submitted for opposition 1
on 17th Sept 2024
Created
Submitted for opposition 31
on 17th Sept 2024
Formalized